FDA Inspection 1267638 — Mohammed M. Milhem, MD
The FDA completed an inspection of Mohammed M. Milhem, MD on Apr 18, 2025 in Iowa City, IA. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- Apr 18, 2025
- Fiscal Year
- 2025
- Product Type
- Biologics
- Project Area
- Bioresearch Monitoring
- Location
- Iowa City, IA (United States)
Additional details
Clinical Investigator (CI)